Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | TAR-binding protein | 0.0065 | 0.3303 | 0.3771 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0017 | 0.0494 | 0.0564 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0149 | 0.8184 | 0.8184 |
Loa Loa (eye worm) | hypothetical protein | 0.0159 | 0.8758 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0049 | 0.2342 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0049 | 0.2342 | 0.2342 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0019 | 0.0638 | 0.0784 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0111 | 0.5966 | 0.8837 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0638 | 0.0784 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0049 | 0.2342 | 0.2674 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0019 | 0.0638 | 0.0784 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0017 | 0.0494 | 0.5 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0638 | 0.0638 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.0638 | 0.0638 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0044 | 0.2063 | 0.8491 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0019 | 0.0638 | 0.0784 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.004 | 0.1851 | 0.7342 |
Toxoplasma gondii | thioredoxin reductase | 0.0049 | 0.2342 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3303 | 0.3303 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0159 | 0.8758 | 0.8758 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0017 | 0.0494 | 0.0494 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.004 | 0.1851 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0019 | 0.0638 | 0.1067 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0123 | 0.6686 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3303 | 0.3303 |
Brugia malayi | TAR-binding protein | 0.0065 | 0.3303 | 0.3771 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0044 | 0.2063 | 0.8491 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0065 | 0.3303 | 0.3771 |
Plasmodium falciparum | glutathione reductase | 0.0049 | 0.2342 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0123 | 0.6686 | 1 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0017 | 0.0494 | 0.0494 |
Schistosoma mansoni | hypothetical protein | 0.018 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0065 | 0.3303 | 0.3771 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0638 | 0.0923 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3303 | 0.3303 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0049 | 0.2342 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0049 | 0.2342 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0049 | 0.2342 | 1 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0017 | 0.0494 | 0.0494 |
Echinococcus granulosus | muscleblind protein | 0.0159 | 0.8758 | 0.8758 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0.0638 | 1 |
Leishmania major | trypanothione reductase | 0.0049 | 0.2342 | 1 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0012 | 0.0233 | 0.0267 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0145 | 0.7941 | 0.7941 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0044 | 0.2063 | 1 |
Schistosoma mansoni | hypothetical protein | 0.018 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3303 | 0.3303 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0149 | 0.8184 | 0.9345 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0123 | 0.6686 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0019 | 0.0638 | 0.0784 |
Echinococcus multilocularis | muscleblind protein | 0.0159 | 0.8758 | 0.8758 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0111 | 0.5966 | 0.8837 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0049 | 0.2342 | 1 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0111 | 0.5966 | 0.8837 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0638 | 0.0923 |
Schistosoma mansoni | tar DNA-binding protein | 0.0065 | 0.3303 | 0.3303 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0012 | 0.0233 | 0.0267 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0123 | 0.6655 | 0.7599 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0123 | 0.6655 | 0.7599 |
Brugia malayi | Thioredoxin reductase | 0.0049 | 0.2342 | 0.2674 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.0638 | 0.0638 |
Echinococcus granulosus | tar DNA binding protein | 0.0065 | 0.3303 | 0.3303 |
Brugia malayi | glutathione reductase | 0.0049 | 0.2342 | 0.2674 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.004 | 0.1851 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.0638 | 0.0729 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.0638 | 0.0729 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0044 | 0.2063 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0049 | 0.2342 | 0.2985 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0111 | 0.5966 | 0.8837 |
Mycobacterium tuberculosis | Probable reductase | 0.0111 | 0.5966 | 0.8837 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0638 | 0.0638 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0123 | 0.6686 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0065 | 0.3303 | 0.3771 |
Loa Loa (eye worm) | hypothetical protein | 0.0159 | 0.8758 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0049 | 0.2342 | 0.2674 |
Loa Loa (eye worm) | acetyltransferase | 0.0149 | 0.8184 | 0.9345 |
Brugia malayi | RNA binding protein | 0.0065 | 0.3303 | 0.3771 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0.0638 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0019 | 0.0638 | 1 |
Echinococcus multilocularis | geminin | 0.018 | 1 | 1 |
Brugia malayi | Muscleblind-like protein | 0.0159 | 0.8758 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0638 | 0.0784 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0019 | 0.0638 | 0.0234 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0044 | 0.2063 | 0.2063 |
Echinococcus multilocularis | tar DNA binding protein | 0.0065 | 0.3303 | 0.3303 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0044 | 0.2063 | 0.8491 |
Brugia malayi | MH2 domain containing protein | 0.0123 | 0.6655 | 0.7599 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0149 | 0.8184 | 0.8184 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0049 | 0.2342 | 0.2342 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0111 | 0.5966 | 0.8837 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0638 | 0.0784 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.